Epigenetic changes in therapy-related MDS/AML
- 19 March 2010
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 184 (1-2), 46-49
- https://doi.org/10.1016/j.cbi.2009.10.013
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Cancer DNA Methylation: Molecular Mechanisms and Clinical ImplicationsClinical Cancer Research, 2009
- Incorporation of 5-chlorocytosine into mammalian DNA results in heritable gene silencing and altered cytosine methylation patternsCarcinogenesis: Integrative Cancer Research, 2009
- Carcinogen-Induced Gene Promoter Hypermethylation Is Mediated by DNMT1 and Causal for Transformation of Immortalized Bronchial Epithelial CellsCancer Research, 2008
- DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an updateMolecular Cancer, 2008
- Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG IslandPLoS Genetics, 2008
- Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid LeukemiasCurrent Medicinal Chemistry, 2008
- Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk CohortCancer Research, 2006
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Comprehensive analysis of CpG islands in human chromosomes 21 and 22Proceedings of the National Academy of Sciences of the United States of America, 2002
- Translating the Histone CodeScience, 2001